Life Science Insights data shows that the percentage of pharma and biotech companies using electronic data capture in trials will grow from only 7% in June 2005 to over 18% in the next 12 months. Another 30% of pharma and biotech companies will be using EDC in 50-90% of their trials in 12 months.